Philip Scheltens

Biografie

Prof. dr. Philip Scheltens studied at the VU University Amsterdam, Netherlands, gaining his MD in 1984, and PhD in 1993. Clinical residencies in neurosurgery and neurology supported his academic development. He is Professor of Cognitive Neurology and Director of the Alzheimer Center at Amsterdam University Medical Centers and Honorary Professor at King’s College London. His main interests are early diagnosis, biomarkers, clinical trials and drug development. He has been the (inter)national PI for over 35 studies, including phase 1-3 multicenter clinical trials. He supervised >75 PhD theses since 2000. He founded the Dutch national plan against dementia and served as chair of the board. He is co-editor-in-chief of Alzheimer’s Research & Therapy and co- leads various EU projects, such as IMI-EPAD, IMI-AMYPAD, EMIF-AD, RADAR-AD, Euro-Fingers. He authored over 1000 peer reviewed papers and > 75 book chapters and co-edited several major text books. He is member of the Royal Dutch Academy of Arts and Sciences (KNAW) and served as Secretary General until 2020. In 2016 he was awarded the European Grand Prix for Alzheimer’s Research. In 2020 he was Knighted in the Order of the Netherlands Lion by the King. Since January 2021 he is also managing partner of the LSP Dementia Fund.
Jaarlijks Lifestyle4Health congres 2021 Leefstijlgeneeskunde bij alzheimer
22 juni 15-18u – wetenschappelijk webinar

Ik steun het Manifest voor Leefstijlgeneeskunde en werk en vind dat leefstijlgeneeskunde een plek moet krijgen in de werkcontext